Casi Pharmaceuticals Inc (CASI)

May 02, 2025

CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia - ACCESS Newswire

May 02, 2025

Apr 28, 2025

StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI) - Defense World

Apr 28, 2025

Apr 20, 2025

CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated by Analysts at StockNews.com - Defense World

Apr 20, 2025

Apr 17, 2025

CASI Pharmaceuticals, Inc.Ordinary Shares (NQ: CASI - FinancialContent

Apr 17, 2025

Apr 12, 2025

Brokers Issue Forecasts for CASI Q1 Earnings - Defense World

Apr 12, 2025

Apr 12, 2025

StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI) - Defense World

Apr 12, 2025

Apr 11, 2025

HC Wainwright Has Lowered Expectations for CASI Pharmaceuticals (NASDAQ:CASI) Stock Price - Defense World

Apr 11, 2025

Apr 10, 2025

CASI stock touches 52-week low at $1.88 amid market challenges - Investing.com

Apr 10, 2025

Apr 09, 2025

CASI Pharmaceuticals Moves to Arbitration in Dispute with Acrotech - TipRanks

Apr 09, 2025

Apr 07, 2025

CASI receives updated buyout offer for China operations - The Pharma Letter

Apr 07, 2025

Apr 05, 2025

CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely - Asianet Newsable

Apr 05, 2025

Apr 03, 2025

CASI Pharma stock hits 52-week low at $1.9 amid market challenges - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely Bullish - MSN

Apr 03, 2025

Apr 03, 2025

CASI Pharmaceuticals receives buyout proposal from CEO By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

CASI Pharma stock hits 52-week low at $1.9 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

CASI Pharmaceuticals Acquires Precision Autoimmune Therapeutics - TipRanks

Apr 03, 2025

Apr 03, 2025

Casi Pharmaceuticals Signs Agreement To Acquire Equity Interests In Precision Autoimmune Therapeutics - marketscreener.com

Apr 03, 2025

Apr 03, 2025

CASI Pharmaceuticals Receives Updated Acquisition Proposal for China Operations - TipRanks

Apr 03, 2025

Apr 03, 2025

CASI Pharmaceuticals receives buyout proposal from CEO - Investing.com

Apr 03, 2025

Apr 03, 2025

CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company - ACCESS Newswire

Apr 03, 2025

Apr 03, 2025

CASI Pharma's CEO Makes Strategic $20M Bid for Entire China BusinessKey Pipeline Assets Included - Stock Titan

Apr 03, 2025

Apr 02, 2025

CASI Pharmaceuticals Full Year 2024 Earnings: US$2.56 loss per share (vs US$2.02 loss in FY 2023) - Yahoo

Apr 02, 2025

Apr 01, 2025

Short Interest in CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Declines By 15.0% - Defense World

Apr 01, 2025

Mar 31, 2025

CASI Pharmaceuticals Reports 2024 Financial Results and Strategic Developments - TipRanks

Mar 31, 2025

Mar 31, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Mar 31, 2025

Mar 31, 2025

CASI Delivers Record Q4 Growth: FDA Clearance Powers Next-Gen Treatment Pipeline - Stock Titan

Mar 31, 2025

Mar 27, 2025

CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com - Defense World

Mar 27, 2025

Mar 21, 2025

CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Shares Lagging The Industry But So Is The Business - Simply Wall St

Mar 21, 2025

Mar 20, 2025

CASI Pharmaceuticals (NASDAQ:CASI) Now Covered by StockNews.com - The AM Reporter

Mar 20, 2025

Mar 11, 2025

CASI Pharma stock hits 52-week low at $2.04 amid market challenges - Investing.com

Mar 11, 2025

Feb 27, 2025

CASI Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 15, 2025

CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated at StockNews.com - Defense World

Feb 15, 2025

Feb 10, 2025

Hypoxia Treatment Market to Witness Substantial Growth by 2031 | - openPR

Feb 10, 2025

Feb 10, 2025

CASI Pharmaceuticals (NASDAQ:CASI) Research Coverage Started at StockNews.com - Defense World

Feb 10, 2025

Feb 10, 2025

Multiple Myeloma Clinical and Non-Clinical Studies, Key - openPR

Feb 10, 2025

Feb 10, 2025

CASI Pharmaceuticals Secures Interim Relief in Juventas Dispute - TipRanks

Feb 10, 2025

Feb 06, 2025

This CASI Pharmaceuticals Insider Increased Their Holding By 65% Last Year - Yahoo Finance

Feb 06, 2025

Feb 03, 2025

Critical Comparison: Biora Therapeutics (NASDAQ:BIOR) versus CASI Pharmaceuticals (NASDAQ:CASI) - Defense World

Feb 03, 2025

Jan 31, 2025

Critical Contrast: Evolus (NASDAQ:EOLS) and Nuvectis Pharma (NASDAQ:NVCT) - Defense World

Jan 31, 2025

Jan 30, 2025

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) Secures EU Patent for FHAB Platform Technology - Defense World

Jan 30, 2025

Jan 27, 2025

Multiple Myeloma Pipeline 2024: FDA Approvals, Therapies, - openPR

Jan 27, 2025